ArticleCNS drugs2017
The Molecular Mechanism of Glucagon-Like Peptide-1 Therapy in Alzheimer's Disease, Based on a Mechanistic Target of Rapamycin Pathway.
Lin LiPubMed ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this paperpooled itcites it